MICHELLE GUILD: Open Payments
NPI 1780231886 · DES PLAINES, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,252 in 58 payments from 15 companies in 2025. Trend: 2023 $160 · 2024 $1,575 · 2025 $1,252
Food & beverage: $1,202Education: $51
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $353 |
| Janssen Biotech, Inc. | 10 | $173 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $139 |
| Ardelyx, Inc. | 3 | $95 |
| QOL Medical, LLC | 3 | $78 |
| PFIZER INC. | 3 | $76 |
| Madrigal Pharmaceuticals | 2 | $68 |
| Ipsen Biopharmaceuticals, Inc | 2 | $54 |
| Lilly USA, LLC | 2 | $45 |
| Phathom Pharmaceuticals, Inc. | 2 | $44 |
Products named: RINVOQ, TREMFYA, ENTYVIO, IBSRELA, LINZESS, Sucraid, REZDIFFRA, IQIRVO.
Industry payments across IL — which companies pay providers there.
